Literature DB >> 15046252

HIV-1 replication and pathogenesis in the human thymus.

Eric G Meissner1, Karen M Duus, Rebecca Loomis, Rhiannon D'Agostin, Lishan Su.   

Abstract

How HIV replicates and causes destruction of the thymus, and how to restore thymic function, are among the most important questions of HIV-1 pathogenesis and therapy in adult as well as pediatric patients. The thymus appears to function, albeit at reduced levels, throughout the life of adults, to respond to T cell depletion induced by HIV and to be suppressed by HIV. In this review, we summarize recent findings concerning HIV replication and pathogenesis in the human thymus, focusing on mechanistic insights gleaned from studies in the SCID-hu Thy/Liv mouse and human fetal-thymus organ culture (HF-TOC) models. First, we discuss HIV viral determinants and host factors involved in the replication of HIV in the thymus. Second, we consider evidence that both viral factors and host factors contribute to HIV-induced thymocyte depletion. We thus propose that multiple mechanisms, including depletion and suppression of progenitor cells, paracrine and direct lytic depletion of thymocytes, and altered thymocyte selection are involved in HIV-induced pathology in the thymus. With the SCID-hu Thy/Liv mouse and HF-TOC models, it will be important in the coming years to further clarify the virological, cell biological, and immunological mechanisms of HIV replication and pathogenesis in human thymus, and to correlate their significance in HIV disease progression.

Entities:  

Mesh:

Year:  2003        PMID: 15046252      PMCID: PMC4425345          DOI: 10.2174/1570162033485258

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  116 in total

Review 1.  Structure--function relationships in HIV-1 Nef.

Authors:  M Geyer; O T Fackler; B M Peterlin
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

2.  Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.

Authors:  D Camerini; H P Su; G Gamez-Torre; M L Johnson; J A Zack; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  HIV-1 infectivity of human T cells in a human/murine chimeric fetal thymic organ culture system.

Authors:  D L Greiner; L D Shultz; D Deluca; J H Leif; S W Christianson; R M Hesselton
Journal:  In Vivo       Date:  1996 Jan-Feb       Impact factor: 2.155

4.  Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers.

Authors:  S H Weiss; J J Goedert; S Gartner; M Popovic; D Waters; P Markham; F di Marzo Veronese; M H Gail; W E Barkley; J Gibbons
Journal:  Science       Date:  1988-01-01       Impact factor: 47.728

5.  Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.

Authors:  S Carl; T C Greenough; M Krumbiegel; M Greenberg; J Skowronski; J L Sullivan; F Kirchhoff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Identification of HIV-1 determinants for replication in vivo.

Authors:  L Su; H Kaneshima; M L Bonyhadi; R Lee; J Auten; A Wolf; B Du; L Rabin; B H Hahn; E Terwilliger; J M Mccune
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

7.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.

Authors:  H Kaneshima; L Su; M L Bonyhadi; R I Connor; D D Ho; J M McCune
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro.

Authors:  H Valentin; M T Nugeyre; F Vuillier; L Boumsell; M Schmid; F Barré-Sinoussi; R A Pereira
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion.

Authors:  N Oyaizu; T W McCloskey; S Than; S Pahwa
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  11 in total

1.  Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope.

Authors:  Eric G Meissner; Karen M Duus; Feng Gao; Xiao-Fang Yu; Lishan Su
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

2.  Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry.

Authors:  Eric G Meissner; Vernon M Coffield; Lishan Su
Journal:  Virology       Date:  2005-06-05       Impact factor: 3.616

3.  Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.

Authors:  Stefan Baenziger; Roxane Tussiwand; Erika Schlaepfer; Luca Mazzucchelli; Mathias Heikenwalder; Michael O Kurrer; Silvia Behnke; Joachim Frey; Annette Oxenius; Helen Joller; Adriano Aguzzi; Markus G Manz; Roberto F Speck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

4.  Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus.

Authors:  Eric G Meissner; Liguo Zhang; S Jiang; Lishan Su
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus.

Authors:  Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  HIV-1 infection and pathogenesis in a novel humanized mouse model.

Authors:  Liguo Zhang; Grigoriy I Kovalev; Lishan Su
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 7.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

8.  The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env.

Authors:  Vijay Sivaraman; Liguo Zhang; Eric G Meissner; Jerry L Jeffrey; Lishan Su
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

Review 9.  Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.

Authors:  Tetsuo Tsukamoto
Journal:  Pharmaceutics       Date:  2019-03-11       Impact factor: 6.321

10.  HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.

Authors:  Jenna B Honeycutt; Angela Wahl; Nancie Archin; Shailesh Choudhary; David Margolis; J Victor Garcia
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.